Phase 3 Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have been diagnosed with epilepsy that is not fully controlled, meaning they have had one or more seizures in the last 6 months that were not caused by an obvious trigger
- People who are currently taking Levetiracetam as their only epilepsy medication
- People who have a documented history of taking Levetiracetam for at least 12 months before joining the trial
- People who are taking a high dose of Levetiracetam, between 1.5 and 3 grams per day
Who may not be able to join:
- People who are under 18 years of age
- People who have received Levetiracetam through an intravenous drip (a needle into a vein) within the last 24 hours
- People who are currently taking any other epilepsy medications alongside Levetiracetam
- People who have taken any other epilepsy medications within the last two weeks
- People who are pregnant
- People who have significant kidney problems, including long-term reduced kidney function or a sudden decline in kidney function (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
change in mean number of Seizure-free days
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.